CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study.

The Tohoku journal of experimental medicine

Volumn 223, Issue 4, 2011, Pages 277-283

  Tan, Kai ^a   Lu, Shuzheng ^b   Chen, Yundai ^b   Song, Xiantao ^b   Wu, Xiaofan ^b   Jin, Zening ^b   Yuan, Fei ^b   Zhou, Yuan ^b   Li, Hong ^b   Yang, Tingshu ^b   Zhou, Yujie ^b   Li, Zhizhong ^b   Chen, Fang ^b   Zhang, Shuyang ^b   Guo, Lijun ^b   Wang, Weimin ^b   Zhao, Quanming ^b   Huo, Yong ^b   Yang, Xinchun ^b   Liu, Jinghua ^b   Chen, Buxing ^b   Yan, Hongbing ^b   Li, Hongwei ^b   Ke, Yuannan ^b   Chen, Keji ^b   Shi, Dazhuo ^b   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BIOLOGICAL MARKER; CXCL16 PROTEIN, HUMAN; SCAVENGER RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOASSAY; BLOOD; CORONARY BLOOD VESSEL; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMOKINES, CXC; CORONARY VESSELS; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, SCAVENGER; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80052049133     PISSN: None     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.223.277     Document Type: Article

References (0)